Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases
Qingyi Shao, Danlei Chen, Wenxia Shao, Qing Ye · 2026
Read Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases by Qingyi Shao, Danlei Chen, Wenxia Shao, Qing Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13260815.txt.
Description
Qingyi Shao and co-authors wrote a 2026 review of CAR T-cell therapy aimed at senescence and age-related disease. Senescent cells are aged cells that stop dividing but secrete inflammatory and scarring signals, driving chronic inflammation and tissue failure. First-wave senolytic drugs that clear them face weak targeting and short-lived effects. CAR T cells, immune cells engineered with synthetic receptors, have proven precise clearance power as living drugs in cancer care.
The review traces the shift of this therapy into aging medicine. Topics include finding and checking surface targets on senescent cells, designs suited to the senescent setting, and early lab evidence of reversed scarring and improved metabolic function. Problems of specificity, safety, and making the cells for clinical use are weighed. Future paths include mRNA delivery and AI, toward treating shared aging pathways rather than single diseases.
Catalog record
| CREATOR | Qingyi Shao, Danlei Chen, Wenxia Shao, Qing Ye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57534 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |